Gout News

The addition of athletic footwear to podiatric care and education failed to improve foot pain in patients with gout, despite short-term improvements in overall pain and impairment, according to recent findings in Arthritis Research & Therapy.

In the ever-changing landscape of the United States health care system, rheumatologists need a voice. They need a voice in managing the complex web of drug pricing structures, a voice in developing clinical guidelines, and, on a fundamental level, a voice in simply communicating with all the players involved in running the day-to-day operations of a rheumatology practice.

DESTIN, Fla. — Patients with gout in chronic kidney disease are undertreated, and health care providers need to do more to help patients with both diseases reach serum urate targets by using existing drugs, but starting slowly, according to Kenneth Saag, MD, MSc, of the University of Alabama at Birmingham.

DESTIN, Fla. — Patients with gout are 50% more likely to develop cancer, with prostate cancer being the most common among that population, according to a presenter at the North American Young Rheumatology Investigator Forum.

More than 620 registered attendees from 45 states and 11 countries are traveling to Destin, Florida, this week for the 2019 Congress of Clinical Rheumatology, scheduled for May 2 to 5, according to David McLain, MD, FACP, FACR, where they will learn about a wide range of topics from speakers they may not hear anywhere else.

The consumption of dietary omega-3 polyunsaturated fatty acids via fish is associated with a lower risk for gout flares, whereas consuming omega-3s exclusively through self-administered supplements has no effect, according to data published in Arthritis & Rheumatology.

Rates of 5-year all-cause mortality and health care use are higher among patients with gout who also have chronic kidney disease, compared with those with only gout, regardless of age, according to findings published in BMC Rheumatology.

Novartis on Monday announced it has acquired the full rights to several of IFM Tre’s research assets, which consists of one clinical and two pre-clinical programs, for a minimum of $310 million, according to a press release.

In an anonymous online survey among patients with self-reported physician-diagnosed gout, nearly a quarter of respondents described frequent sleep disorders, as well as daytime sleepiness.

The FDA has approved a liquid formulation of colchicine for the prophylaxis of gout flares among adult patients, according to a company press release.